Skip to main content

Advertisement

Log in

Hemithyroidectomy in Papillary Thyroid Cancers: A Prospective, Single Institutional Surgical Audit and Contemplating on the Clinical Implications of 2015 American Thyroid Association Guidelines

  • Original Article
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

Papillary thyroid carcinoma (PTC) contributes to 88% of thyroid malignancies and its extent of surgical management has been a topic of debate in the past 2 decades. American thyroid association (ATA) recommendations have been periodically updated for its robust and evidence-based management. We present our experience in implementing 2015 ATA guidelines, assessment of surgical outcomes of hemithyroidectomy in PTC ≤ 4 cm and contemplating on the potential clinical implications of 2015 ATA guidelines. A prospective study in a cohort of Bethesda class V and VI PTC with nodule ≤ 4 cm who underwent Hemithyroidectomy between 2012 and 2020. Data on thyroid nodule evaluation, management, histopathology and follow up were used for risk stratification. Of 37 patients, 27 (72.9%) were low risk and 10 (37%) were intermediate risk ATA group. 4 (40%) intermediate risk patients had structural incomplete response and underwent completion thyroidectomy. 1 (2.7%) out of 4 completion surgery patients required adjuvant radio-ablation iodine (RAI) and 3 patients were under surveillance. Overall, 2 (5.4%) of 37 patients, 1 each from low and intermediate groups were given remnant RAI in view of aggressive histology, old age and unwillingness for a completion surgery. During follow up of 4.94 ± 2.4 years, 35 (94.5%) showed excellent response and 2 (5.4%) showed biochemical incomplete response. The difference in RFS between two groups was statistically significant with p < 0.001. Thyroid preserving surgery combined with real time risk stratification seems appropriate for low and intermediate risk PTC ≤ 4 cm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

Not applicable.

Code Availability

Not applicable.

References

  1. Sherman SI (2003) Thyroid carcinoma. Lancet. 361(9356):501–511

    Article  PubMed  Google Scholar 

  2. Vaisman F, Momesso D, Bulzico DA, Pessoa CH, da Cruz MDG, Dias F et al (2013) Thyroid lobectomy is associated with excellent clinical outcomes in properly selected differentiated thyroid cancer patients with primary tumors greater than 1 cm. J Thyroid Res 2013:398194

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kuba S, Yamanouchi K, Hayashida N, Maeda S, Adachi T, Sakimura C et al (2017) Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: comparative analysis after propensity score matching: a multicenter study. Int J Surg 38:143–148

    Article  PubMed  Google Scholar 

  4. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedus L et al (2010) American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and european thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract 16(3):468–475

    Article  PubMed  Google Scholar 

  5. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ et al (2009) Revised american thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11):1167–1214

    Article  PubMed  Google Scholar 

  6. Mendelsohn AH, Elashoff DA, Abemayor E, St John MA (2010) Surgery for papillary thyroid carcinoma: is lobectomy enough? Arch Otolaryngol Head Neck Surg 136:1055–106111

    Article  PubMed  Google Scholar 

  7. Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD et al (2014) Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg 260(4):601–605

    Article  PubMed  Google Scholar 

  8. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) 2015 American thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–33

    Article  PubMed  PubMed Central  Google Scholar 

  9. Cibas ES, Ali SZ (2009) The Bethesda system for reporting thyroid cytopathology. Thyroid 19(11):1159–1165

    Article  PubMed  Google Scholar 

  10. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16(2):109–142

    Article  PubMed  Google Scholar 

  11. Rahbari R, Zhang L, Kebebew E (2010) Thyroid cancer gender disparity. Future Oncol 6(11):1771–1779

    Article  CAS  PubMed  Google Scholar 

  12. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913–2921

    Article  CAS  PubMed  Google Scholar 

  13. Cetta F, Montalto G, Gori M, Curia MC, Cama A, Olschwang S (2000) Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 85(1):286–292

    CAS  PubMed  Google Scholar 

  14. Mankarios D, Baade P, Youl P, Mortimer RH, Onitilo AA, Russell A et al (2014) Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer. Endocrine 46(2):300–308

    Article  CAS  PubMed  Google Scholar 

  15. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH et al (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291(2):228–238

    Article  CAS  PubMed  Google Scholar 

  16. Ahn D, Lee GJ, Sohn JH, Jeon JH (2020) Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma. Head Neck 42(5):1004–1013

    Article  PubMed  Google Scholar 

  17. Brassard M, Borget I, Edet-Sanson A, Giraudet AL, Mundler O, Toubeau M et al (2011) Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. J Clin Endocrinol Metab 96(5):1352–1359

    Article  CAS  PubMed  Google Scholar 

  18. Momesso DP, Vaisman F, Yang SP, Bulzico DA, Corbo R, Vaisman M et al (2016) Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine. J Clin Endocrinol Metab 101(7):2692–2700

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Trimboli P, La Torre D, Ceriani L, Condorelli E, Laurenti O, Romanelli F et al (2013) High sensitive thyroglobulin assay on thyroxine therapy: can it avoid stimulation test in low and high risk differentiated thyroid carcinoma patients? Horm Metab Res 45(9):664–668

    Article  CAS  PubMed  Google Scholar 

  20. Horvath E, Majlis S, Rossi R, Franco C, Niedmann JP, Castro A et al (2009) An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab 94(5):1748–1751

    Article  CAS  PubMed  Google Scholar 

  21. Redman R, Yoder BJ, Massoll NA (2006) Perceptions of diagnostic terminology and cytopathologic reporting of fine-needle aspiration biopsies of thyroid nodules: a survey of clinicians and pathologists. Thyroid 16(10):1003–1008

    Article  PubMed  Google Scholar 

  22. Bernstein JM, Shah M, McMillan C, Freeman JL (2016) Institution-specific risk of papillary thyroid carcinoma in atypia/follicular lesion of undetermined significance. Head Neck 38(Suppl1):E1210–E1215

    Article  PubMed  Google Scholar 

  23. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z et al (2009) Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94(6):2092–2098

    Article  CAS  PubMed  Google Scholar 

  24. Collet JF, Lacave R, Hugonin S, Poulot V, Tassart M, Fajac A (2016) BRAF V600E detection in cytological thyroid samples: a key component of the decision tree for surgical treatment of papillary thyroid carcinoma. Head Neck 38(7):1017–1021

    Article  PubMed  Google Scholar 

  25. Lesnik D, Cunnane ME, Zurakowski D, Acar GO, Ecevit C, Mace A et al (2014) Papillary thyroid carcinoma nodal surgery directed by a preoperative radiographic map utilizing CT scan and ultrasound in all primary and preoperative patients. Head Neck 36(2):191–202

    Article  PubMed  Google Scholar 

  26. Haugen BR (2015) American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: What is new and What has changed? Cancer. 123(3):372 –3 81

  27. Abdul-Sater L, Henry M, Majdan A, Mijovic T, Franklin JH, Brandt MG et al (2011) What are thyroidectomy patients really concerned about? Otolaryngol Head Neck Surg 144:685–6905

    Article  PubMed  Google Scholar 

  28. Soylu L, Ozbas S, Uslu HY, Kocak S (2007) The evaluation of the causes of subjective voice disturbances after thyroid surgery. Am J Surg 194(3):317–322

    Article  PubMed  Google Scholar 

  29. De Carlucci D Jr, Tavares MR, Obara MT, Martins LA, Hojaij FC, Cernea CR (2008) Thyroid function after unilateral total lobectomy: risk factors for postoperative hypothyroidism. Arch Otolaryngol Head Neck Surg.  134(10):1076–1079

  30. Gupta K, Panda NK, Jain P, Bakshi J, Verma R (2015) Hypothyroidism after hemithyroidectomy for colloid goiter: is it a reality. Thyroid Res Pract 12:107–109

    Article  Google Scholar 

  31. Zhang C, Li Y, Li J, Chen X (2020) Total thyroidectomy versus lobectomy for papillary thyroid cancer: a systematic review and meta-analysis. Medicine 99(6):e19073

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

None.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naresh K. Panda.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Ethics Approval

Institutional ethics committee approval was taken prior to beginning of the study with approval number “NK/7071/Study/130”.

Consent to Participate

A verbal consent of the patient and/or their guardian was taken at every step of investigation and treatment.

Consent for Publication

A verbal Consent was taken for use of patient’s treatment related data for academic use and publication on the condition of anonymity.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rathod, R., Panda, N.K., Bakshi, J. et al. Hemithyroidectomy in Papillary Thyroid Cancers: A Prospective, Single Institutional Surgical Audit and Contemplating on the Clinical Implications of 2015 American Thyroid Association Guidelines. Indian J Otolaryngol Head Neck Surg 75, 508–516 (2023). https://doi.org/10.1007/s12070-022-03312-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-022-03312-w

Keywords

Navigation